Talphera Reports Q1 2026 Loss Raises Going Concern and Nasdaq Compliance Concerns Ultragenyx Pharmaceutical RARE at 2639 Buy Sell or Hold 20260514 Biotech Sector Outlook Fidelity Weighs In on Health Care Stock Trends